Cargando…
Improved efficacy of mesenchymal stromal cells stably expressing CXCR4 and IL-10 in a xenogeneic graft versus host disease mouse model
Previous clinical trials have shown that mesenchymal stromal cells (MSCs) can modulate graft versus host disease (GvHD) after allogeneic hematopoietic transplantation, although with variable efficacy. To improve the anti-GvHD effect of these cells, adipose tissue derived-human MSCs (Ad-MSCs) were tr...
Autores principales: | Hervás-Salcedo, Rosario, Fernández-García, María, Hernando-Rodríguez, Miriam, Suárez-Cabrera, Cristian, Bueren, Juan A., Yáñez, Rosa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929539/ https://www.ncbi.nlm.nih.gov/pubmed/36817457 http://dx.doi.org/10.3389/fimmu.2023.1062086 |
Ejemplares similares
-
Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10
por: Hervás-Salcedo, Rosario, et al.
Publicado: (2021) -
The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
por: García-Bernal, David, et al.
Publicado: (2021) -
Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model
por: Fernández-García, María, et al.
Publicado: (2015) -
Cell Therapy With Mesenchymal Stem Cells Induces an Innate Immune Memory Response That Attenuates Experimental Colitis in the Long Term
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2020) -
Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation
por: Tago, Yoshiyuki, et al.
Publicado: (2021)